Fungal species of the genus Malassezia are part of the normal microbiome of healthy human skin. The most common species are M. sympodialis, M. globosa, M. restricta. A link has been found between hypersensitivity to specific Malassezia allergens and atopic dermatitis and allergic respiratory diseases. More than 30 specific Malassezia allergens have been identified, which show cross-reactivity with allergens from other fungi.
About 20 Malassezia spp. allergens are recognized by WHO/IUIS. Studied molecular allergens of M. sympodialis (Mala s 5, 6, 10, 14) show similarity to human proteins. Sensitization is associated with bronchial asthma, allergic rhinitis, atopic eczema. Mal f1 triggers the TH22/TH17 pathway, explaining reduced effectiveness of some therapies. MGL_1304 causes strong allergic reactions in patients with allergic dermatitis and cholinergic urticaria. Skin barrier defects enhance sensitization to these allergens.
FEIA (Fluorescence Enzyme Immunoassay), ImmunoCAP (Solid-phase Immunofluorescence) – quantitative determination.
Please note that the research method and reference values may vary depending on the equipment and test systems used.